Biogen profit rises as new multiple sclerosis drug shines
Biogen Idec Inc said on Wednesday its new, high-profile oral multiple sclerosis drug Tecfidera had sales of $398 million in the fourth quarter, easily...
Source: http://health.yahoo.net/news/s/nm/biogen-profit-rises-as-new-multiple-sclerosis-drug-shines
No comments:
Post a Comment